Free Trial
ASX:CYP

Cynata Therapeutics (CYP) Stock Price, News & Analysis

About Cynata Therapeutics Stock (ASX:CYP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
159,853 shs
Average Volume
N/A
Market Capitalization
A$57.60 million
P/E Ratio
N/A
Dividend Yield
13.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cynata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYP Stock News Headlines

Cynata Therapeutics Ltd (51S.SG) - Yahoo Finance
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

CYP Stock Analysis - Frequently Asked Questions

Cynata Therapeutics Limited (ASX:CYP) announced its quarterly earnings results on Wednesday, February, 27th. The company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). Cynata Therapeutics had a negative net margin of 420.82% and a negative trailing twelve-month return on equity of 100.01%.

Company Calendar

Last Earnings
2/27/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CYP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.74 million
Net Margins
-420.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$2.32 million
Price / Cash Flow
11.93
Book Value
A$0.04 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$57.60 million
Optionable
Not Optionable
Beta
0.93
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (ASX:CYP) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners